(NTR) Nutrien - Ratings and Ratios
Exchange: NYSE •
Country: Canada •
Currency: USD •
Type: Common Stock •
ISIN: CA67077M1086
Fertilizers, Crop Nutrients, Seeds, Crop Protection, Services
Dividends
| Dividend Yield | 4.40% |
| Yield on Cost 5y | 6.65% |
| Yield CAGR 5y | 4.66% |
| Payout Consistency | 100.0% |
| Payout Ratio | 54.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 27.9% |
| Value at Risk 5%th | 44.9% |
| Relative Tail Risk | -2.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 26.50 |
| CAGR/Max DD | -0.04 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.382 |
| Beta | 0.408 |
| Beta Downside | 0.421 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.33% |
| Mean DD | 28.31% |
| Median DD | 29.54% |
Description: NTR Nutrien December 17, 2025
Nutrien Ltd. (NYSE:NTR) is a vertically integrated crop-input provider operating through four segments: Nutrien Ag Solutions (distribution of nutrients, crop protection, seeds, and related services), Potash (granular and standard potash products), Nitrogen (ammonia, urea, and other nitrogen solutions), and Phosphate (solid and liquid fertilizers plus industrial/feed products). Headquartered in Saskatoon, Canada, the company was formed in 2017 through the merger of Agrium and PotashCorp.
Key recent metrics: FY 2023 revenue reached approximately $27.4 billion with an EBITDA margin near 15 %; net debt stood at roughly $6.5 billion, and the firm maintained a dividend yield around 3.5 %. Economic drivers include global grain production growth (which fuels fertilizer demand), volatile nitrogen pricing linked to natural gas costs, and tightening potash supply due to limited new capacity. A sector-wide catalyst is the accelerating adoption of precision-agriculture and climate-smart nitrogen technologies, which can boost premium product uptake.
For a concise, data-rich overview of Nutrien’s valuation and risk profile, the ValueRay platform provides a useful dashboard to explore further.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income (1.80b TTM) > 0 and > 6% of Revenue (6% = 1.59b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -0.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.82% (prev 10.98%; Δ 4.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 4.14b > Net Income 1.80b (YES >=105%, WARN >=100%) |
| Net Debt (13.56b) to EBITDA (5.61b) ratio: 2.42 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (485.8m) change vs 12m ago -1.84% (target <= -2.0% for YES) |
| Gross Margin 30.19% (prev 29.06%; Δ 1.13pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 51.20% (prev 51.16%; Δ 0.04pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.66 (EBITDA TTM 5.61b / Interest Expense TTM 691.6m) >= 6 (WARN >= 3) |
Altman Z'' 2.68
| (A) 0.08 = (Total Current Assets 14.47b - Total Current Liabilities 10.27b) / Total Assets 51.83b |
| (B) 0.23 = Retained Earnings (Balance) 11.84b / Total Assets 51.83b |
| (C) 0.06 = EBIT TTM 3.22b / Avg Total Assets 51.87b |
| (D) 0.94 = Book Value of Equity 25.06b / Total Liabilities 26.67b |
| Total Rating: 2.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 53.58
| 1. Piotroski 6.0pt |
| 2. FCF Yield 5.23% |
| 3. FCF Margin 8.35% |
| 4. Debt/Equity 0.56 |
| 5. Debt/Ebitda 2.42 |
| 6. ROIC - WACC (= 1.05)% |
| 7. RoE 7.31% |
| 8. Rev. Trend -36.84% |
| 9. EPS Trend -56.40% |
What is the price of NTR shares?
As of December 17, 2025, the stock is trading at USD 61.85 with a total of 2,871,965 shares traded.
Over the past week, the price has changed by +5.44%, over one month by +8.53%, over three months by +10.08% and over the past year by +37.56%.
Over the past week, the price has changed by +5.44%, over one month by +8.53%, over three months by +10.08% and over the past year by +37.56%.
Is NTR a buy, sell or hold?
Nutrien has received a consensus analysts rating of 3.88.
Therefore, it is recommended to buy NTR.
- Strong Buy: 10
- Buy: 5
- Hold: 8
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the NTR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 65.7 | 6.3% |
| Analysts Target Price | 65.7 | 6.3% |
| ValueRay Target Price | 67.9 | 9.8% |
NTR Fundamental Data Overview December 10, 2025
Market Cap USD = 28.79b (28.79b USD * 1.0 USD.USD)
P/E Trailing = 15.9353
P/E Forward = 11.8483
P/S = 1.1216
P/B = 1.1612
P/EG = 0.6101
Beta = 1.155
Revenue TTM = 26.56b USD
EBIT TTM = 3.22b USD
EBITDA TTM = 5.61b USD
Long Term Debt = 9.85b USD (from longTermDebt, last quarter)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 14.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.56b USD (from netDebt column, last quarter)
Enterprise Value = 42.35b USD (28.79b + Debt 14.18b - CCE 624.0m)
Interest Coverage Ratio = 4.66 (Ebit TTM 3.22b / Interest Expense TTM 691.6m)
FCF Yield = 5.23% (FCF TTM 2.22b / Enterprise Value 42.35b)
FCF Margin = 8.35% (FCF TTM 2.22b / Revenue TTM 26.56b)
Net Margin = 6.79% (Net Income TTM 1.80b / Revenue TTM 26.56b)
Gross Margin = 30.19% ((Revenue TTM 26.56b - Cost of Revenue TTM 18.54b) / Revenue TTM)
Gross Margin QoQ = 32.70% (prev 30.42%)
Tobins Q-Ratio = 0.82 (Enterprise Value 42.35b / Total Assets 51.83b)
Interest Expense / Debt = 1.19% (Interest Expense 168.1m / Debt 14.18b)
Taxrate = 26.37% (166.1m / 629.9m)
NOPAT = 2.37b (EBIT 3.22b * (1 - 26.37%))
Current Ratio = 1.41 (Total Current Assets 14.47b / Total Current Liabilities 10.27b)
Debt / Equity = 0.56 (Debt 14.18b / totalStockholderEquity, last quarter 25.12b)
Debt / EBITDA = 2.42 (Net Debt 13.56b / EBITDA 5.61b)
Debt / FCF = 6.12 (Net Debt 13.56b / FCF TTM 2.22b)
Total Stockholder Equity = 24.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.48% (Net Income 1.80b / Total Assets 51.83b)
RoE = 7.31% (Net Income TTM 1.80b / Total Stockholder Equity 24.66b)
RoCE = 9.33% (EBIT 3.22b / Capital Employed (Equity 24.66b + L.T.Debt 9.85b))
RoIC = 6.38% (NOPAT 2.37b / Invested Capital 37.15b)
WACC = 5.33% (E(28.79b)/V(42.97b) * Re(7.52%) + D(14.18b)/V(42.97b) * Rd(1.19%) * (1-Tc(0.26)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.92%
[DCF Debug] Terminal Value 71.70% ; FCFE base≈2.26b ; Y1≈1.57b ; Y5≈801.3m
Fair Price DCF = 32.02 (DCF Value 15.48b / Shares Outstanding 483.3m; 5y FCF grow -35.86% → 3.0% )
EPS Correlation: -56.40 | EPS CAGR: -22.06% | SUE: 0.30 | # QB: 0
Revenue Correlation: -36.84 | Revenue CAGR: -5.23% | SUE: 0.84 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.56 | Chg30d=+0.048 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=4.58 | Chg30d=+0.062 | Revisions Net=+1 | Growth EPS=-2.8% | Growth Revenue=+0.8%
P/E Trailing = 15.9353
P/E Forward = 11.8483
P/S = 1.1216
P/B = 1.1612
P/EG = 0.6101
Beta = 1.155
Revenue TTM = 26.56b USD
EBIT TTM = 3.22b USD
EBITDA TTM = 5.61b USD
Long Term Debt = 9.85b USD (from longTermDebt, last quarter)
Short Term Debt = 3.37b USD (from shortTermDebt, last quarter)
Debt = 14.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.56b USD (from netDebt column, last quarter)
Enterprise Value = 42.35b USD (28.79b + Debt 14.18b - CCE 624.0m)
Interest Coverage Ratio = 4.66 (Ebit TTM 3.22b / Interest Expense TTM 691.6m)
FCF Yield = 5.23% (FCF TTM 2.22b / Enterprise Value 42.35b)
FCF Margin = 8.35% (FCF TTM 2.22b / Revenue TTM 26.56b)
Net Margin = 6.79% (Net Income TTM 1.80b / Revenue TTM 26.56b)
Gross Margin = 30.19% ((Revenue TTM 26.56b - Cost of Revenue TTM 18.54b) / Revenue TTM)
Gross Margin QoQ = 32.70% (prev 30.42%)
Tobins Q-Ratio = 0.82 (Enterprise Value 42.35b / Total Assets 51.83b)
Interest Expense / Debt = 1.19% (Interest Expense 168.1m / Debt 14.18b)
Taxrate = 26.37% (166.1m / 629.9m)
NOPAT = 2.37b (EBIT 3.22b * (1 - 26.37%))
Current Ratio = 1.41 (Total Current Assets 14.47b / Total Current Liabilities 10.27b)
Debt / Equity = 0.56 (Debt 14.18b / totalStockholderEquity, last quarter 25.12b)
Debt / EBITDA = 2.42 (Net Debt 13.56b / EBITDA 5.61b)
Debt / FCF = 6.12 (Net Debt 13.56b / FCF TTM 2.22b)
Total Stockholder Equity = 24.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.48% (Net Income 1.80b / Total Assets 51.83b)
RoE = 7.31% (Net Income TTM 1.80b / Total Stockholder Equity 24.66b)
RoCE = 9.33% (EBIT 3.22b / Capital Employed (Equity 24.66b + L.T.Debt 9.85b))
RoIC = 6.38% (NOPAT 2.37b / Invested Capital 37.15b)
WACC = 5.33% (E(28.79b)/V(42.97b) * Re(7.52%) + D(14.18b)/V(42.97b) * Rd(1.19%) * (1-Tc(0.26)))
Discount Rate = 7.52% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.92%
[DCF Debug] Terminal Value 71.70% ; FCFE base≈2.26b ; Y1≈1.57b ; Y5≈801.3m
Fair Price DCF = 32.02 (DCF Value 15.48b / Shares Outstanding 483.3m; 5y FCF grow -35.86% → 3.0% )
EPS Correlation: -56.40 | EPS CAGR: -22.06% | SUE: 0.30 | # QB: 0
Revenue Correlation: -36.84 | Revenue CAGR: -5.23% | SUE: 0.84 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.56 | Chg30d=+0.048 | Revisions Net=-2 | Analysts=7
EPS next Year (2026-12-31): EPS=4.58 | Chg30d=+0.062 | Revisions Net=+1 | Growth EPS=-2.8% | Growth Revenue=+0.8%
Additional Sources for NTR Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle